Product Comparison


 

No Image

Grifols Therapeutics 13533013101
Merck 00006483703
Merck 00006468100
Merck 00006412102
McKesson # 1113109 981867 911398 304337 952614
Description TABLE, OR INSTR MOBILE S/STL ADJ MANUAL 34"X42" Td Vaccine 7 Years of Age and Older Tetanus and Diphtheria Toxoids Adsorbed Injection Single Dose Vial 0.5 mL Pneumovax® 23 Pneumonia Vaccine Adults 50 Years of Age and Older Pneumococcal 23 Vaccine Polyvalent 25 mcg / 0.5 mL Injection Prefilled Syringe 0.5 mL M-M-R® II MMR Vaccine 12 Months of Age and Older Measles, Mumps, and Rubella Vaccine, Preservative Free Injection Single Dose Vial 0.5 mL Gardasil® 9 Human Papillomavirus Vaccine (HPV) For Females 9 to 45 Years of Age / Males 9 through 45 Years of Age 20 mcg - 60 mcg / 0.5 mL Injection Prefilled Syringe Intramuscular
Manufacturer # T0082-344213533013101000064837030000646810000006412102
Brand   Pneumovax® 23M-M-R® IIGardasil® 9
Manufacturer MAC MEDICAL INCGrifols TherapeuticsMerckMerckMerck
Invoice TABLE, OR INSTR MOBILE S/STL ADJ MANUAL 34"X42"TDVAX, SDV 0.5ML (10/PK)PNEUMOVAX, SYR 0.5ML (10/CT)M-M-R II, SDV (10/BX)GARDASIL 9 HPV VACC, SYR 0.5ML(10/BX) MRKVAC
    Log In to Order   Log In to Order   Log In to Order   Log In to Order   Log In to Order

Comparison

Alternate Manufacturer Number 3422953
Application Td VaccinePneumonia VaccineMMR VaccineHuman Papillomavirus Vaccine (HPV)
Container Type Single Dose VialPrefilled SyringeSingle Dose VialPrefilled Syringe
Country of Origin United StatesUnknownUnited StatesUnited StatesUnited States
Dosage Form InjectionInjectionInjectionInjection
Generic Drug Code 20835438599956837568
Generic Drug Name Tetanus and Diphtheria Toxoids AdsorbedPneumococcal 23 Vaccine PolyvalentMeasles, Mumps, and Rubella Vaccine, Preservative FreeHuman Papillomavirus 9-Valent Vaccine, Recombinant, Preservative Free
NDC Number 13533013101000064837030000646810000006-4121-02
Product Dating McKesson Acceptable Dating: we will ship >= 180 daysMcKesson Acceptable Dating: we will ship >= 180 daysMcKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 180 days
Storage Requirements Requires RefrigerationRequires RefrigerationRequires RefrigerationRequires Refrigeration
Strength 2 Lf - 2 Lf / 0.5 mL25 mcg / 0.5 mL1,000 TCID - 12,500 TCID - 1,000 TCID / 0.5 mL20 mcg - 60 mcg / 0.5 mL
Type IntramuscularIntramuscular or SubcutaneousSubcutaneousIntramuscular
UNSPSC Code 51201629512016155120162851201649
User 7 Years of Age and OlderAdults 50 Years of Age and Older12 Months of Age and OlderFor Females 9 to 45 Years of Age / Males 9 through 45 Years of Age
Volume 0.5 mL0.5 mL0.5 mL0.5 mL
Features and Benefits
  • PNEUMOVAX 23 is a vaccine indicated for active immunization for the prevention of pneumococcal disease caused by the 23 serotypes contained in the vaccine
  • PNEUMOVAX 23 is approved for use in persons 50 years of age or older and persons aged >2 years who are at increased risk for pneumococcal disease
  • Box of 10 single-dose, pre-filled Luer-Lok™ syringes with tip caps, color coded with a violet plunger rod and purple stripe on the syringe labels and cartons
  • Store unopened and opened vials at 2° - 8°C (36° - 46°F)
  • Preservative free
  • M-M-R II* is supplied as: (1) a box of 10 single-dose vials of lyophilized vaccine and (2) a box of 10 vials of diluent
  • Store vials at 2 - 8 degrees Celsius (36 - 46 degrees Fahrenheit)
  • The diluent may be stored in the refrigerator with the lyophilized vaccine or separately at room temperature
  • GARDASIL 9 is a non-infectious recombinant 9-valent vaccine prepared from the purified virus-like particles (VLPs) of the major capsid (L1) protein of HPV Types 6, 11, 16, 18, 31, 33, 45, 52, and 58
  • Each 0.5-mL dose contains approximately 30 mcg of HPV Type 6 L1 protein, 40 mcg of HPV Type 11 L1 protein, 60 mcg of HPV Type 16 L1 protein, 40 mcg of HPV Type 18 L1 protein, 20 mcg of HPV Type 31 L1 protein, 20 mcg of HPV Type 33 L1 protein, 20 mcg of HPV Type 45 L1 protein, 20 mcg of HPV Type 52 L1 protein, and 20 mcg of HPV Type 58 L1 protein
  • Administer GARDASIL 9 intramuscularly as a 0.5-mL dose at the following schedule: 0, 2 months, 6 months
  • Not all vulvar, vaginal, and anal cancers are caused by HPV, and GARDASIL 9 protects only against those vulvar, vaginal, and anal cancers caused by HPV 16, 18, 31, 33, 45, 52 and 58